Showing results (231-240 of 273) with videos related to
Sort By:
Pageof 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapyA H Sarris, I Braunschweig, L J Medeiros, et al.Blood|March 1, 1991
Stages I and II diffuse large cell lymphomas: prognostic factors and long-term results with CHOP-bleo and radiotherapyW S Velasquez, L M Fuller, S Jagannath, et al.Digestive Diseases and Sciences|August 5, 1998
Colitis and colon cancer in cotton-top tamarins (Saguinus oedipus oedipus) living wild in their natural habitatJ D Wood, O C Peck, K S Tefend, et al.International Journal of Radiation Oncology, Biology, Physics|January 11, 1992
Radiotherapy during pregnancy for clinical stages IA-IIA Hodgkin's diseaseS Y Woo, L M Fuller, J H Cundiff, et al.Leukemia & Lymphoma|May 30, 2001
Hodgkin's disease in patients infected with human immunodeficiency virus: frequency, presentation and clinical outcomeA M Tsimberidou, A H Sarris, L J Medeiros, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1993
Hodgkin's disease: study of treatment intensities and incidences of second malignanciesM A Rodriguez, L M Fuller, S O Zimmerman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Cyclosporin A does not reverse clinical resistance to paclitaxel in patients with relapsed non-Hodgkin's lymphomaA H Sarris, A Younes, P McLaughlin, et al.International Journal of Radiation Oncology, Biology, Physics|October 23, 1997
Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignanciesM T Vlachaki, C S Ha, F B Hagemeister, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1991
Discordant bone marrow involvement in diffuse large-cell lymphoma: a distinct clinical-pathologic entity associated with a continuous risk of relapseL E Robertson, J R Redman, J J Butler, et al.The British Journal of Surgery|March 3, 2016
Impact of multimodal therapy in locally recurrent rectal cancerY N You, J M Skibber, C-Y Hu, et al.Pageof 28